High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study
Conclusion If statin therapy reflects the history of previous hyperlipidaemia, high levels of antiphospholipid antibodies may be a marker for earlier endothelial damage caused by hyperlipidaemia. (Source: Journal of Clinical Pathology)

EP News: Clinical
Lakkireddy et al (J Am Coll Cardiol 2012;59:1168–1174, PMID 22305113) evaluated the safety of dabigatran (D) during atrial fibrillation ablation in a multicenter, observational study of consecutive patients at 8 centers. All patients had the D dose held on the morning of the procedure. A total of 290 patients, including 145 taking D, and an equal number of matched patients taking uninterrupted warfarin (W), were included in the study. Three thromboembolic complications (2.1%) occurred in the D group compared with none in the W group (P (Source: Heart Rhythm)